KHAN NAJAT (CEO and President) received a stock award from RECURSION PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 2 awards
Filed: 2/10/2026ACC: 0001601830-26-000014
DirectorOfficer· CEO and President
Since Feb 2026
+1.69M
Net shares
Net buyer
$41.2K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
1.70M acquired · 10.36K disposed
Non-Derivative Transactions3
Class A Common Stock
Direct
Shares
+1.67M
Price / share
—
Trade value
—
% of position
273.8%
2/6/2026
611.13K→2.28M
Class A Common Stock
Direct
Shares
+30.35K
Price / share
—
Trade value
—
% of position
1.3%
2/6/2026
2.28M→2.32M
Class A Common Stock
Direct
Shares
−10.36K
Price / share
$3.98
Trade value
$41.25K
% of position
0.4%
2/6/2026
2.32M→2.30M
Total
Net shares
+1.69M
Net value
-$41.25K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 2/6/2026 | A · Award | +1.67M | — | — | 273.8% | 611.13K | 2.28M |
| Class A Common Stock Direct | 2/6/2026 | A · Award | +30.35K | — | — | 1.3% | 2.28M | 2.32M |
| Class A Common Stock Direct | 2/6/2026 | F · Tax Withholding | −10.36K | $3.98 | $41.25K | 0.4% | 2.32M | 2.30M |
| Total | +1.69M | -$41.25K | ||||||
Derivative Transactions0
No derivative transactions reported